https://www.selleckchem.com/products/abt-199.html
05) and overall survival ( 0.05), and positive expression of LRP correlated only with shorter DFS ( 0.05). BT-474 showed chemosensitivity to paclitaxel and epirubicin, while MDA-MB-231 showed chemosensitivities to paclitaxel, epirubicin, carboplatin, and fluorouracil (T/C ≤ 50%). The basal-like and HER2+ breast cancer primary cells showed chemosensitivities to paclitaxel and epirubicin with significant differences compared with luminal breast cancer primary cells ( 0.05). The differential expression of drug resistance gen
Like
Comment
Share
